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Introduction 
Percutaneous Endoscopic Gastrostomy (PEG) was first described in 1980 (Gauderer, 
1980), superseding surgical gastrostomy as a means of providing long-term enteral 
nutrition.  Despite the commonality of this procedure, its associated morbidity and 
mortality rates are significant, with directly attributable rates of 1:30 and 1:150 
respectively.  
Poor patient selection and poor management are the principal factors contributing 
towards adverse outcomes. The 2004 National Confidential Enquiry into Patient 
Outcomes and Death (National Confidential Enquiry, 2004) recorded that 19% of 
PEG procedures performed were ‘futile or not indicated at all’. This article provides a 
practical approach to avoiding and treating complications associated with PEG 
feeding.  
 
Avoiding Complications 
Three factors are important when contemplating PEG insertion: ‘Patient’, ‘Procedure’ 
and ‘Preparation’. Each case should be considered on its own merits, taking into 
account the clinical scenario, underlying diagnosis and prognosis, patient wishes, 
ethical issues, and expected impact on quality of life. 
 
Appropriate patient?  
Table 1 describes the common indications for PEG feeding, and Box 1 
contraindications.  It is indicated in patients expected to be unable to maintain 
adequate oral intake for at least 2-3 weeks (Löser, 2005), in the absence of limited life 
expectancy.  
The issue of PEG use in advanced dementia is contentious. Although there have been 
concerns that procedural risks may be much higher in these individuals, there is 
variability between case series and much of the observational data have potential 
confounding factors (Dharmarajan et al, 2001; Higaki et al, 2008). Nonetheless, there 
is currently no clear evidence that PEG feeding increases survival, reduces risk of 
aspiration or improves quality of life in this patient cohort. Consequently, the decision 
to proceed with an invasive procedure requires careful consideration and sensitive 
discussion about realistic goals of treatment (Peck et al, 2014). 
Ethical considerations often arise in relation to artificial nutritional support. 
Therefore, it is important to take a multi-disciplinary team approach when assessing 
patient suitability for PEG insertion. In UK law, tube feeding is regarded as a medical 
treatment, requiring patient consent. The physician is ultimately responsible for the 
decision to provide, withhold or withdraw supplemental nutrition to an adult patient 
lacking mental capacity (in the absence of an advance directive or person with 
medical power of attorney). Family members and the patient next-of-kin should be 
consulted (or an Independent Mental Capacity Advocate (IMCA) if none available), 
but generally do not have formal decision-making responsibility (Lennard-Jones, 
2000). Ethical considerations regarding adjunctive feeding in anorexia are described 
in a Royal College of Physicians report published in 2010 (Royal College of 
Physicians, 2010). Feeding should never be withheld unless it is deemed futile by the 
clinical team. Adjunctive feeding can be provided for patients being treated for 
anorexia nervosa against their will.  
 
 
Appropriate procedure? 
The enteral feeding method should match the patient's needs. Nasogastric tube (NGT) 
feeding should be used when the anticipated duration required is less than 3 weeks 
(Löser, 2005), with nasojejunal tube (NJT) feeding in those at risk from aspiration. A 
jejunal extension tube (JET) can be fitted to PEG tubes if aspiration of gastric 
contents has been demonstrated or suspected, although this may not be preventative.  
 
Appropriate preparation? 
Box 2 summarises a number of practical considerations that are helpful in optimising 
outcomes of PEG placement. In particular: 
 
• Blood tests taken within the previous 5 days need exclude coagulopathy in patients 
at risk of bleeding (aim for INR <1.5), thrombocytopaenia (aim for platelet count 
>50-80 x109/L), and significant anaemia (aim for haemoglobin >100 g/L) (Löser, 
2005).  
• Stop drugs that interfere with coagulation. Warfarin should be held for 5 days prior 
to PEG insertion (with demonstration of INR normalisation), dabigatran or 
rivaroxaban for 3 days, and apixaban for 2 days (Scaglione, 2013). High risk 
patients can be bridged with low molecular weight heparin (LMWH), which should 
be stopped 24 hours prior to the procedure. Prophylactic dose LMWH and low dose 
aspirin can be continued. Clopidogrel should be held for 7 days in patients at low 
risk of thrombosis, but first discuss with a cardiologist in high-risk patients (e.g. 
recent coronary artery stents). 
• MRSA-colonised patients should have topical suppression therapy prior to PEG 
placement. 
• Treat overt sepsis prior to PEG insertion. 
• Ensure patient nil by mouth for at least 8 hours before procedure, but essential 
medication should be given (e.g. anti-Parkinson’s therapy or anticonvulsants). 
• PEG should be performed in the morning, so that immediate complications can be 
recognised within working hours.  
• Periprocedural IV antibiotics (e.g. ceftriaxone) should be administered.  
• Medical and nursing staff should adhere to post-procedure advice. 
 
 
Complications of PEG  
The PEG procedure has been quoted as having a 30-day mortality rate of between 
10% and 29% (O’Toole, 2006), mostly related to underlying co-morbidity such as 
advanced dementia (Abuksis, 2000). Mortality rates associated directly with the 
procedure are considerably lower (0.7-2%). Major complications occur after about 
3% of procedures, whereas minor complications occur in over 20%. Rates are similar 
regardless of the PEG technique used (O’Toole, 2006). They are more common in the 
context of malignant disease, severe malnutrition, extreme old age, diabetes and 
hypoalbuminaemia. Complications associated with PEG are shown in Table 2. 
 
Immediate complications 
Haemorrhage 
Blood loss can prove fatal following PEG insertion. If due to vessel damage, it may 
respond to tightening the intra-gastric flange against the skin. If haemodynamic 
instability persists, interventional angiography or surgery may be necessary. 
 
Recommendations: 
Correct coagulopathy prior to PEG insertion (Veitch, 2009). Endoscopists must have 
adequate training to minimise the number of passes made with the trochar at the time 
of PEG insertion. 
 
Peritonitis 
Peritonitis can occur either immediately following the procedure, or soon after 
feeding commences. It typically presents with fever, abdominal pain and leukocytosis. 
 
Recommendations: 
Peritonitis occurring before feeding has commenced, or following colonic perforation, 
requires exploratory laparotomy (Westaby, 2010). Peritonitis, without colonic 
perforation as confirmed by CT scan, can be managed conservatively with IV 
antibiotics; withhold PEG feeding until clinically resolved. 
 
Bowel perforation 
This usually occurs following catheter protrusion through an anterior transverse 
colon. It may present acutely with abdominal pain, bowel obstruction or peritonitis. 
More often, however, it manifests following tube replacement with undigested feed 
passing per rectum or faecal material refluxing through the PEG, when the tip of the 
feeding tube lies in the colon. Ultrasound or CT are diagnostic. It is important to note 
that sub-diaphragmatic air (pneumo-peritoneum) is present after approximately 20% 
of PEG placements; this does not indicate perforation nor does it require intervention 
(Wiesen, 2006). 
 
Recommendations: 
Peritonitis following bowel perforation mandates emergency laparotomy. Otherwise, 
the PEG tube should not be used nor removed. Provide broad-spectrum antibiotics for 
4 weeks, by which time the fistula tract will have formed and the tube can be 
retracted. The aberrant fistulous tract will then gradually close. 
 
 
Delayed complications 
 
Dislodgment 
Patients may attend the Emergency Department reporting that their PEG tube has 
fallen out.  
 
Recommendations: 
The tract closes within 12-24 hours, so without delay pass a new, balloon-stabilised 
enteral tube or a low profile "button" (Rosenberger et al, 2011). If delay is likely, 
patency of an established tract can be maintained by passing an appropriately sized 
catheter; a 12 French Foley catheter often used, however a balloon gastrostomy tube 
is preferable if available. However, this should not be done if the PEG was created 
within the past month; instead a separately sited endoscopic or radiologic inserted 
gastrostomy (RIG) should be placed, followed by radiological exclusion of an 
ongoing leak before feeding commences. Try to avoid traction-removable tubes if 
dislodgement is recurrent. 
 
Catheter occlusion 
Over time, many PEG tubes become blocked due to the incorrect administration of 
medication or inappropriate flushing. 
 
Recommendations: 
Ensure that the tube is flushed with warm water following administration of feed or 
medication (Scott and Bowling, 2015). Do not use saline as there is a risk of 
crystallisation, nor wires or needles. Blocked tubes can be vigorously flushed with 
warm water, and alkalinized enzymes may help (e.g. Creon granules, completely 
dissolved in alkaline water made using alkaline drops available over-the-counter). 
Tubes can be used immediately once patent. Discuss with pharmacy whether any 
medications are incompatible with PEG administration. 
 
Leakage 
This is often due to excessive lateral tube motion or over-tight fixation of the PEG to 
the skin surface, causing pressure necrosis. 
 
Recommendations: 
Exclude distal intestinal obstruction and treat any cutaneous infection. Wider bore 
catheters usually still leak; often the PEG tube needs to be re-sited, having removed 
the original PEG a few days earlier. 
 
Cellulitis and granulation tissue 
Peristomal cellulitis used to be common in the week following PEG, occurring in 
approximately 15%. This has been reduced to about 3% with the use of peri-
procedural antibiotics (Ahmad, 2003). It presents with localised erythema and 
tenderness. Systemic upset is rare and antibiotics may not be required. Infections are 
most commonly due to Staphylococcus aureus or β-haemolytic streptococci. Candida 
super-infection may also occur. Granulation tissue can occur at the skin surface, and 
become infected or bleed. 
 
Recommendations: 
Treatment involves regular antiseptic wound cleaning, sometimes supplemented by 
antibiotic therapy (refer to local guidelines for treatment of skin and soft tissue 
infections) (O’Toole, 2006). The PEG may need to be removed and infection treated 
before a new tube is sited. Granulation tissue can be treated surgically or by local 
application of silver nitrate. 
 
Diarrhoea 
This is usually due to intolerance to the feed (Scott, 2015). Very rarely, it may be 
caused by a gastrocolic fistula, which can be asymptomatic for months.  
 
Recommendations: 
Initially, try reduced osmolarity or low fibre feeds. Small doses of loperamide may 
also be helpful. A gastrocolic fistula is diagnosed by ultrasound or CT scan and can 
be managed by re-siting the PEG, as the residual track closes within days. This may 
require laparoscopic replacement if colonic interposition is present; this approach also 
allows excision of any residual fistula (Stroud, 2003). 
 
Obstruction 
Gastric outlet obstruction can occur if the internal flange lodges in the pylorus or 
duodenum, most frequently after replacement when PEG traction is not required. This 
presents with reflux of stomach contents adjacent to the PEG.  
 
Recommendations: 
Diagnosis is usually based on clinical symptoms and signs. Management involves 
partially withdrawing the tube and reaffixing it, usually with the 4 cm marker at the 
skin surface. Gastroparesis is an alternative diagnosis. 
 
Buried bumper 
This rare, but now well-recognised, complication arises when gastric mucosa over-
grows the internal flange, and then occludes the tube lumen (Lee and Lin, 2008). 
Patients often complain of abdominal pain during feeding. This is believed to occur 
following excessive tension between the inner and outer bolsters.  
 
Recommendations: 
Endoscopic examination usually allows the bumper to be released using a needle 
knife sphincterotome; the PEG tube should then be replaced. It can be prevented by 
loosening the external fixation device to allow 10 mm “free play” the day following 
PEG placement, and thereafter rotating the tube every few days. 
 
Reflux and aspiration 
This is common following long-term PEG feeding, particularly in patients with 
delayed gastric emptying. Pulmonary aspiration should be suspected if acidic feed can 
be aspirated from the mouth or in the context of chest infections.  
 
Recommendations: 
Avoid medication that predispose to constipation or delayed gastric emptying, such as 
opioids or drugs with anticholinergic effects. Correct any electrolyte disturbances, 
reduce the rate of feed, avoid feeding the patient when supine, and prescribe 
prokinetics (e.g. metoclopramide) (O’Toole, 2006). A JET can be used but often will 
kink or revert into the stomach, in which case a surgically-placed jejunostomy or a 
PEJ should be considered. 
 
Cosmetic 
PEG tubes, particularly in younger patients, can be socially inhibiting. 
 
Recommendations: 
A button system can be placed once a fistulous tract is formed (> 4 weeks), although 
this must be routinely replaced every 6 months (Löser, 2005). There is no need to 
routinely change standard PEG tubes, and some have stayed in situ for over 10 years. 
 
 
Conclusions 
This article has highlighted the common adverse events associated with PEG tubes, as 
well as techniques to avoid and overcome them. Further information can be obtained 
from society guidelines (Westaby, 2010) or specialist texts (Marks and Harbord, 
2013). Patient selection and preparation prior to the procedure is paramount to 
mitigate the appreciable risk of complications. The PEG procedure requires senior 
endoscopist input, and should be undertaken within the context of input from both 
hospital and community nutrition teams. Multi-professional support is crucial to 
prevent, detect and manage early and late complications. 
 
 
 
 
 
 
 Key points 
 
1. Avoiding inappropriate patient selection is key to reducing risk of mortality 
(1:150) and serious morbidity (1:30). 
2. Careful preparation prior to PEG insertion minimizes complications. 
3. PEG should be performed in the morning, by an experienced team. 
4. Access to hospital and community multi-professional team members should be 
anticipated. 
5. Most PEG complications can be easily resolved in expert hands. 
 
 
 
 
Top tips 
1. Patients with advanced dementia need very careful consideration and discussion 
prior to proceeding to PEG. 
2. Pneumonia causes the majority of early deaths after PEG placement. Early 
recognition and treatment is key. 
3. Flush PEGs with warm water after each administration of food or medication to 
maintain patency. Do not use saline. 
4. Peristomal infection may respond simply to local wound clearing. If moderate or 
severe, or associated with systemic upset, prescribe antibiotics according to local 
guidelines. 
5. If a PEG becomes dislodged, replace it within 12 hours otherwise the track will 
close. Foley catheters can be used as a temporizing measure should there be any delay. 
PEGs that have been in situ for less than 1 month will likely need to be re-sited.  
6. In patients with recurrent aspiration despite PEG insertion, useful measures 
include: stopping drugs that impede gastric emptying; reducing the rate of feed 
administration; avoid feeding while supine; administering prokinetics; and 
attaching a PEJ extension. 
 
 
 Table 1. Indication for PEG: Adapted from (Stroud, 2003) 
 
Indications  Example 
Selected cognitive impairment Head injury, stroke,  dementia in carefully 
selected cases 
Neurologically unsafe swallow Stroke, multiple sclerosis, motor neurone 
disease, Parkinson’s disease, cerebral palsy 
Mechanical disorders of swallowing Oropharyngeal and oesophageal malignancy 
or strictures, facial injury requiring 
reconstructive surgery with prolonged 
recovery 
Partial failure of intestinal function, where 
nutritional requirements cannot be met by oral 
intake alone 
Short bowel syndrome, fistulae, cystic 
fibrosis, Crohn's disease, palliative drainage 
of gastric secretions in presence of chronic GI 
stenosis/ileus 
 
 
 
 Box 1. Contraindications to PEG: Adapted from (Löser, 2005) 
 
Serious coagulation disorders (INR >1.4, platelets <50-80 x109/L) 
Interposed organs (e.g. liver, colon) 
Marked peritoneal carcinomatosis 
Severe ascites 
Peritonitis 
Planned oesophagectomy 
Severe psychosis 
Limited life expectancy 
End-stage dementia (unless multidisciplinary agreement procedure in patient best 
interests) 
 
Prior abdominal surgery is not a contraindication, but is associated with a higher risk 
of colonic perforation. Intra-abdominal varices constitute a relative contraindication. 
 
 
 Box 2. Avoiding complications: Adapted from (Löser, 2005) 
 
Prior to procedure 
Optimise nutritional state  
Treat intercurrent sepsis 
Normalise haemoglobin, platelets and coagulation parameters 
Obtain informed consent 
Fast for at least 8 hours (except for essential tablets) 
Peri-procedural antibiotic prophylaxis 
 
Subsequent to procedure 
Maintain low tension traction on external fixation plate for 24 hours 
Loosen external fixation device to 1 cm from the skin surface after 24 hours 
Rotate feeding tube 360° weekly (unless jejunal extension tube in situ) 
Clean tube and renew dressings, initially daily 
Nutrients can be administered 4 hours after uncomplicated tube placement 
Ensure multi-professional support via nutrition team 
 
 
 Table 2. PEG, early complications 
 
Complication Prevention Management 
Early Complications   
Post-procedural 
pneumonia 
Treat sepsis prior to PEG 
placement.  
Optimise mouth care. 
RIG if ventilatory 
impairment. 
Avoid throat analgesia and 
excess sedation during 
insertion; use liberal oral 
suction 
Early identification and 
antibiotic therapy 
Bleeding Delay PEG if 
coagulopathy 
Apply traction to internal 
bumper. Consider surgery. 
Early peristomal infection Optimal wound care. 
Avoid excessive tightening 
of external fixator 
Local antisepsis ± 
systemic antibiotic therapy  
Peritonitis Experienced endoscopist 
to place PEG 
Exploratory laparotomy if 
occurs prior to feed, or if 
radiology demonstrates 
displaced bumper or 
leakage into peritoneal 
cavity. Otherwise 
conservative management 
with antibiotics 
Displacement (early) Ensure traction maintained 
on internal bumper for 4 
weeks after PEG, allowing 
10 mm “play”. 
Consider replacement 
under radiologic guidance 
if within 2-4 weeks of 
initial placement. 
 
 
Table 3. PEG, late complications 
 
Late Complications   
Aspiration pneumonia JET unless impaired 
airway protection. 
Remain at least semi-
recumbent for 60 min post 
feed. 
Avoid bolus feeding. 
Prevent/treat delayed 
gastric emptying. 
Avoid constipation 
Antibiotic therapy 
Displacement (late) Avoid traction-removal 
PEG tubes in confused 
patients.  
Check traction-removal 
PEG internal balloon 
Replace balloon-retained  
or low-profile PEG within 
24 h 
 
weekly 
Leakage and peristomal 
infection 
Prevent excessive lateral 
movement (maintain 
external fixator at no more 
than 1 cm) 
Air dry skin and use 
barrier cream. 
Consider antibiosis. 
Proton pump inhibitor + 
prokinetics. 
Consider tube removal for 
≈ 1 day. 
Resite PEG. 
Stoma granulation Optimal wound care Steroid/antibiotic 
ointment. 
Silver nitrate or argon 
plasma cautery 
Buried bumper Rotate feeding tube 360˚ 
weekly (unless JET). 
Avoid over-tightening 
external fixator 
Endoscopic release then 
PEG replacement. 
JET tube to maintain 
nutrition if bumper cannot 
be removed 
Colo-cutaneous fistula Experienced endoscopist Resite PEG if mature 
fistulous tract 
Metastasis from oro-
pharyngeal or oesophageal 
malignancy 
PEG placement using 
direct puncture technique; 
or place RIG 
Oncology advice 
Tube blockage Careful flushing after 
feed/medication 
Warm water flush. 
Alkaline pancreatic 
enzyme flush. 
Avoid saline flush. 
Fluoroscopic guidewire 
 
JET, jejunal extension tube; PEG, percutaneous endoscopic gastrostomy; RIG, 
radiologic inserted gastrostomy. 
 
References  
 
1. Abuksis G, Mor M, Segal N, et al. Percutaneous endoscopic gastrostomy: high 
mortality rates in hospitalized patients. Am J Gastroenterol 2000;95:128-32 
2. Ahmad I, Mouncher A, Abdoolah A, et al. Antibiotic prophylaxis for percutaneous 
endoscopic gastrostomy--a prospective, randomised, double-blind trial. Aliment 
Pharmacol Ther 2003;18:209-15. 
3. Dharmarajan TS, Unnikrishnan D, Pitchumoni CS. Percutaneous endoscopic 
gastrostomy and outcome in dementia. Am J Gastroenterol 2001;96:2556-63. 
4. Gauderer MW, Ponsky JL, Izant RJ, Jr. Gastrostomy without laparotomy: a 
percutaneous endoscopic technique. J Pediatr Surg 1980;15:872-5. 
5. Higaki F, Yokota O, Ohishi M. Factors predictive of survival after percutaneous 
endoscopic gastrostomy in the elderly: is dementia really a risk factor? Am J 
Gastroenterol 2008;103:1011-6; quiz 1017. 
6. Lee TH, Lin JT. Clinical manifestations and management of buried bumper syndrome 
in patients with percutaneous endoscopic gastrostomy. Gastrointest Endosc 
2008;68:580-4. 
7. Lennard-Jones JE. Ethical and legal aspects of clinical hydration and nutritional 
support. BJU Int 2000;85:398-403. 
8. Löser C, Aschl G, Hebuterne X, et al. ESPEN guidelines on artificial enteral nutrition-
-percutaneous endoscopic gastrostomy (PEG). Clin Nutr 2005;24:848-61. 
9. Marks D, Harbord M. Emergencies in Gastroenterology and Hepatology. Oxford, 
England: Oxford University Press, 2013. 
10. NCEPOD. Scoping our practice. The 2004 report of the National Confidential Enquiry 
into Patient Outcome and Death. National Confidential Enquiry into Patient Outcome 
and Death. London, 2004. 
11. O’Toole P. Complications associated with the placement of percutaneous endoscopic 
gastrostomy. . Volume 2015. London: British Society of Gastroenterology, 2006. 
12. Peck GE, Dani M, Torrance A, et al. Artificial feeding in patients with advanced 
dementia. Br J Hosp Med (Lond) 2014;75:C2-4. 
13. Rosenberger LH, Newhook T, Schirmer B, et al. Late accidental dislodgement of a 
percutaneous endoscopic gastrostomy tube: an underestimated burden on patients and 
the health care system. Surg Endosc 2011;25:3307-11. 
14. Royal College of Physicians and British Society of Gastroenterology. Oral feeding 
difficulties and dilemmas: A guide to practical care, particularly towards the end of 
life. London: Royal College of Physicians, 2010.  
15. Scaglione F. New oral anticoagulants: comparative pharmacology with vitamin K 
antagonists. Clin Pharmacokinet 2013;52:69-82. 
16. Scott R, Bowling TE. Enteral tube feeding in adults. J R Coll Physicians Edinb 
2015;45:49-54. 
17. Stroud M, Duncan H, Nightingale J. Guidelines for enteral feeding in adult hospital 
patients. Gut 2003;52 Suppl 7:vii1-vii12. 
18. Veitch AM, Baglin TP, Gershlick AH, et al. Guidelines for the management of 
anticoagulant and antiplatelet therapy in patients undergoing endoscopic procedures. 
Gut 2008;57:1322-9. 
19. Westaby D, Young A, O'Toole P, et al. The provision of a percutaneously placed 
enteral tube feeding service. Gut 2010;59:1592-605. 
20. Wiesen A, Sideridis K, Fernandes A et al. True incidence and clinical significance of 
pneumoperitoneum after PEG placement: a prospective study. Gastrointest Endosc 
2006;64(6):886-9. 
